Beijing Hotgen Biotech Co Ltd Strategic Asset Allocation Index
Beijing Hotgen Biotech Co Ltd strategic asset allocation index. Beijing Hotgen Biotech Co Ltd (688068) has a Strategic Asset Allocation Index of 31.5% as of June 2023. Strategic assets (PP&E of CN¥1.08 Billion plus long-term investments of CN¥-) total CN¥1.08 Billion, measured against net assets of CN¥3.43 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Beijing Hotgen Biotech Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Beijing Hotgen Biotech Co Ltd (2016–2021)
Strategic asset allocation index of Beijing Hotgen Biotech Co Ltd from 2016 to 2021. This chart shows how Beijing Hotgen Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 31.5%, representing strategic assets of CN¥1.08 Billion against net assets of CN¥3.43 Billion CNY. Check 688068 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Beijing Hotgen Biotech Co Ltd Strategic Asset Allocation Index by Year (2016–2021)
Beijing Hotgen Biotech Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Hotgen Biotech Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Beijing Hotgen Biotech Co Ltd (688068) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 19.6% | CN¥562.12 Million | CN¥562.12 Million | CN¥- | CN¥2.87 Billion | ▼ -12.2 pp |
| 2020 | 31.8% | CN¥237.38 Million | CN¥237.38 Million | CN¥- | CN¥746.79 Million | ▲ +8.6 pp |
| 2019 | 23.2% | CN¥150.48 Million | CN¥150.48 Million | CN¥- | CN¥649.30 Million | ▼ -31.0 pp |
| 2018 | 54.2% | CN¥113.99 Million | CN¥113.99 Million | CN¥- | CN¥210.44 Million | ▲ +24.2 pp |
| 2017 | 30.0% | CN¥48.46 Million | CN¥48.46 Million | CN¥- | CN¥161.65 Million | ▲ +5.0 pp |
| 2016 | 24.9% | CN¥32.67 Million | CN¥32.67 Million | CN¥- | CN¥130.98 Million | — |